Prognostic value of imaging biomarkers in patients with hepatocellular carcinoma treated with liver Transplantation

Prognostic value of imaging biomarkers in patients with hepatocellular carcinoma treated with liver Transplantation - HAIRPIN-study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027969

Enrollment

200

Registered

2023-02-22

Start date

2022-03-08

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22.0

Interventions

Group 1: It is a retrospective study, the hospital's electronic database will be searched for all patients who received liver transplantation, and for all patients, pre-transplantation CT and MRI imag

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who underwent liver transplantation in our center with a diagnosis of HCC.

Exclusion criteria

Exclusion criteria: missing data of the transplantation no proven diagnosis of HCC

Design outcomes

Primary

Measure	Time frame
The goal is the best possible identification of HCC patients who experience a high probability of HCC recurrence after liver transplantation	—

Secondary

Measure	Time frame
Preoperative CT and MRI data sets should therefore be analyzed and evaluated using a multi-stage approach.	—

Countries

Germany

Contacts

Public ContactMoritz Wildgruber

LMU München

moritz.wildgruber@med.uni-muenchen.de+4989440076642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026